Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.

about

Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.

Item

http://www.wikidata.org/entity/Q36719740

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Self-reported treatment-associ ...... henylbutyrate clinical trials.

@ast

Self-reported treatment-associ ...... henylbutyrate clinical trials.

@en

type

Item

label

Self-reported treatment-associ ...... henylbutyrate clinical trials.

@ast

Self-reported treatment-associ ...... henylbutyrate clinical trials.

@en

prefLabel

Self-reported treatment-associ ...... henylbutyrate clinical trials.

@ast

Self-reported treatment-associ ...... henylbutyrate clinical trials.

@en

P1476

Self-reported treatment-associ ...... phenylbutyrate clinical trials

@en

P2093

Andreas Schulze

http://www.w3.org/2001/XMLSchema#string

Annette Feigenbaum

http://www.w3.org/2001/XMLSchema#string

Brendan H Lee

http://www.w3.org/2001/XMLSchema#string

Bruce F Scharschmidt

http://www.w3.org/2001/XMLSchema#string

Cary O Harding

http://www.w3.org/2001/XMLSchema#string

Cynthia Le Mons

http://www.w3.org/2001/XMLSchema#string

David Kronn

http://www.w3.org/2001/XMLSchema#string

Dennis Bartholomew

http://www.w3.org/2001/XMLSchema#string

Derek Wong

http://www.w3.org/2001/XMLSchema#string

Dion F Coakley

http://www.w3.org/2001/XMLSchema#string

P2860

Note on the sampling error of the difference between correlated proportions or percentages

Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion

Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.

Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.

Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.

Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.

Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.

Ammonia control in children with urea cycle disorders (UCDs); phase 2 comparison of sodium phenylbutyrate and glycerol phenylbutyrate.

P304

29-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMGME.2015.08.002

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P50

Susan A. Berry

Jerry Vockley

P577

2015-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26296711

http://www.w3.org/2001/XMLSchema#string

P932

4804346

http://www.w3.org/2001/XMLSchema#string